ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Research Progress in the Treatment of Systemic Lupus Erythematosus with Belimumab Xiaonisha
July 25, 2025Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with an unclear pathogenesis that can affect multiple organs throughout the body, primarily including the kidneys, joints, nervous system, and hematological system. -
China grants approval to GSK’s Benlysta for lupus nephritis treatment Pharmaceutical-Technology
February 14, 2022China’s National Medical Products Administration (NMPA) has granted approval to GlaxoSmithKline’s (GSK) Benlysta (belimumab) to treat active lupus nephritis (LN) in adults. -
FDA approves first treatment for pediatric patients with lupus worldpharmanews
April 28, 2019FDA approves first treatment for pediatric patients with lupus.
Pharma Sources Insight July 2025
